Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 3)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Too Much Cinnamon May Interfere With Some Medications, Study Shows
MONDAY, May 5, 2025 — Consuming too much cinnamon might affect how your body absorbs some medications, new research shows. The study — published in the June issue of the journal Food Chemistry: Mol...
High Blood Pressure, Diabetes More Fatal For Men
FRIDAY, May 2, 2025 – Men are more likely than women to die from high blood pressure, diabetes and HIV/AIDS, after shrugging off medical care for the conditions, a new study says. These differences...
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
WEDNESDAY, April 30, 2025 – Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study published online March...
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 – Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and...
Umbilical Cord Could Contain Clues For Child's Future Health
FRIDAY, April 25, 2025 – Doctors might be able to predict a newborn's long-term health outlook, by analyzing their umbilical cord blood, a new study says. Genetic clues found in cord blood can offer...
FDA and Novo Nordisk Alert Consumers to Counterfeit Ozempic
MONDAY, April 21, 2025 – The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic (semaglutide) and to...
Pregnancy Complications Affect Future Heart Health
FRIDAY, April 18, 2025 – Complications during pregnancy can mean a woman’s future heart health is at risk, particularly if she is overweight or obese, a new study says. Women who are carrying excess ...
First Weight-Loss Pill From Lilly, Orforglipron, Shows Promising Results
FRIDAY, April 18, 2025 — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people w...
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM
THURSDAY, April 17, 2025 – Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are associated with a reduced risk for Alzheimer disease...
Certain Combinations of Food Additives May Increase Risk for Type 2 Diabetes
WEDNESDAY, April 16, 2025 – Two widely consumed food additive mixtures may increase type 2 diabetes incidence, according to a study published online April 8 in PLOS Medicine. Marie Payen de la...
Adverse Events From Semaglutide Seen in the ED Usually GI-Related
TUESDAY, April 15, 2025 – The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a...
Tirzepatide Dispensations Increased Rapidly After Approval
TUESDAY, April 15, 2025 – After approval, tirzepatide dispensations increased markedly among adults with type 2 diabetes prescribed glucose-lowering medications (GLMs) and among adults without...
Home-Delivered Medical Meals Could Prevent Millions Of Hospitalizations A Year
MONDAY, April 14, 2025 – Home-delivered meals tailored to people’s chronic illnesses can prevent hospitalizations, help folks remain healthy and save billions of dollars each year, a new study says. ...
American College of Physicians, April 3-5
The annual meeting of the American College of Physicians (Internal Medicine Meeting) was held from April 3 to 5 in New Orleans and was attended by internal medicine physicians, adult medicine s...
2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes
THURSDAY, April 10, 2025 – Among U.S. adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to 2022, reaching annual prevalence of 0.4 percent...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Mounjaro, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... Jardiance, liraglutide, tirzepatide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, Glucophage, Humulin N